Topic: Liver Diseases
(Reuters) - Bristol-Myers Squibb Co said on Thursday its liver cancer drug brivanib failed to meet the primary endpoint in a late-stage clinical trial.Brivanib failed to meet the main goal of improving overall survival versus placebo in liver cancer patients who failed ...
NEW YORK (Reuters) - Bristol-Myers Squibb Co and Johnson & Johnson plan to jointly develop experimental treatments for hepatitis C in a market worth billions of dollars.The drugs being developed by the two companies work by blocking different proteins than those attacked ...
More than 150 Chinese villagers, many of them children, may have been infected with hepatitis C by a clinic that reused old needles, state media and local authorities said Wednesday.Nineteen people who received treatment at the privately-run clinic in central China have ...
(Reuters) - Gilead Sciences Inc struck a deal to buy biotechnology company Pharmasset Inc for about $11 billion in a huge and risky bet on the next generation of hepatitis C treatments.Gilead, the world's largest maker of HIV drugs, will pay $137 ...
(Reuters) - Gilead Sciences Inc struck a deal to buy biotechnology company Pharmasset Inc for about $11 billion in a huge bet on the next generation of hepatitis C treatments.Gilead, the world's largest maker of HIV drugs, will pay $137 per share ...
(Reuters) - Gilead Sciences Inc struck a deal to buy Pharmasset Inc for about $11 billion in a huge bet on hepatitis C treatments to diversify its portfolio.Gilead, the world's largest maker of HIV drugs, will pay $137 per share for each ...
Doctors said they had cured a baby boy of a life-threatening liver disease using a pioneering treatment in which cells are injected into the abdomen.The team from London's King's College Hospital treated eight-month old Iyaad Syed by injecting him with a group ...
British doctors said they had cured a baby boy of a life-threatening liver disease using a pioneering treatment in which cells are injected into the abdomen.The team from London's King's College Hospital treated eight-month old Iyaad Syed by injecting him with a ...
Former world heavyweight champion Joe Frazier, battling advanced liver cancer, is in the prayers of his most famous rival -- Muhammad Ali."The news about Joe is hard to believe and even harder to accept," Ali, who fought a famed trilogy of bouts ...
(Reuters) - Pharmasset Inc said it started a late-stage trial of its experimental hepatitis C drug, sending the pharmaceutical company's shares up as much as 12 percent.The study will seek to ascertain whether the drug, PSI-7977, taken orally along with ribavirin -- ...